The store will not work correctly when cookies are disabled.
4-((2-Amino-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-benzenesulfonamide
ID: ALA4099596
PubChem CID: 137661645
Max Phase: Preclinical
Molecular Formula: C13H11N7O2S
Molecular Weight: 329.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1c[nH]c2nc(N)nc(Nc3ccc(S(N)(=O)=O)cc3)c12
Standard InChI: InChI=1S/C13H11N7O2S/c14-5-7-6-17-11-10(7)12(20-13(15)19-11)18-8-1-3-9(4-2-8)23(16,21)22/h1-4,6H,(H2,16,21,22)(H4,15,17,18,19,20)
Standard InChI Key: XRUSSNUKOCIDFS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
17.1486 -15.2460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5614 -15.9559 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.9698 -15.2435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6937 -18.8077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6926 -19.6273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4006 -20.0362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3988 -18.3989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1074 -18.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1122 -19.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8923 -19.8712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3696 -19.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8845 -18.5467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9845 -20.0353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1314 -17.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3794 -16.9917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3964 -17.5817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6875 -17.1752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6884 -16.3588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9803 -15.9524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2728 -16.3631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2779 -17.1845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9865 -17.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8574 -16.3692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
5 13 1 0
14 15 3 0
12 14 1 0
7 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 2 1 0
2 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.35 | Molecular Weight (Monoisotopic): 329.0695 | AlogP: 0.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 163.57 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.55 | CX Basic pKa: 5.46 | CX LogP: 0.86 | CX LogD: 0.86 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.55 | Np Likeness Score: -1.47 |
References
1. Anthony NG, Baiget J, Berretta G, Boyd M, Breen D, Edwards J, Gamble C, Gray AI, Harvey AL, Hatziieremia S, Ho KH, Huggan JK, Lang S, Llona-Minguez S, Luo JL, McIntosh K, Paul A, Plevin RJ, Robertson MN, Scott R, Suckling CJ, Sutcliffe OB, Young LC, Mackay SP.. (2017) Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers., 60 (16): [PMID:28737909] [10.1021/acs.jmedchem.7b00484] |